GREGORY SCOTT HAGEMAN portrait
  • Professor, Ophthalmology & Visual Science
801-213-2174

Research Keywords

  • The Biology, Genetics and Development of Diagnostic and Therapeutic Modalities for the Treatment of Age-Related Macular Degeneration and its Co-Segregating Diseases

Presentations

  • Invited Speaker, Sequenom, Inc., San Diego, CA. , , 2012.
  • Invited Speaker, Allergan, Inc., Irvine, CA. , , 2012.
  • Invited Speaker, Regeneron Pharmaceuticals, Inc., White Plains, NY. , , 2012.
  • Invited Speaker, Versant Ventures, Salt Lake City, Utah. , , 2012.
  • Invited Speaker, Insception Biosciences Inc., Salt Lake City, Utah. , , 2012.
  • Invited Speaker, Allergan, Inc., Irvine, CA. , , 2012.
  • Invited Speaker, Sequenom, Inc., San Diego, California. , , 2012.
  • Invited Speaker, Allergan, Inc., Irvine, California. , , 2012.
  • Invited Speaker, Pfizer Inc., New York City, New York. , , 2012.
  • Invited Speaker, Third Rock Ventures, Boston, Massachusetts. , , 2012.
  • Invited Speaker, Sequenom, Inc., San Diego, California. , , 2012.
  • Invited Speaker, Versant Ventures, One Focus Ventures, Salt Lake City, Utah. , , 2012.
  • Invited Speaker, Third Rock Ventures, Toward the Development of Therapeutics & Diagnostics for AMD & Its Co-segregating Diseases", Third Rock Ventures, Boston, MA. , , 2012.
  • Invited Speaker, Genentech, Inc., San Francisco, CA, "Toward the Development of Therapeutics & Diagnostics for AMD & Its Co-segregating Diseases". , , 2012.
  • Invited Speaker, ForSight Labs, LLC, "Toward the Development of Therapeutics & Diagnostics for AMD & Its Co-segregating Diseases". , , 2012.
  • Invited Speaker, Alexion Pharmaceuticals, Boston, Massachusetts, "Toward the Development of Therapeutics & Diagnostics for AMD & Co-segregating Diseases". , , 2011.
  • Invited Speaker, Myrexis, Inc., Salt Lake City, Utah, "Toward the Development of Therapeutics & Diagnostics for AMD & Co-segregating Diseases". , , 2011.
  • Invited Speaker, Pfizer Inc., San Francisco, CA. , , 2011.
  • Invited Speaker, MDB Capital Group, Salt Lake City, Utah, "Toward the Development of Therapeutics & Diagnostics for AMD & Co-segregating Diseases". , , 2011.
  • Invited Speaker, Genentech, Inc., San Francisco, CA. , , 2011.
  • Invited Speaker, Sequenom, Inc. , , 2010.
  • Advisory Board, Sequenom, Inc., Sequenom, Inc, Chair, Clinical Advisory Board. , , 2010.
  • Invited Speaker, Allergan, Inc., Irvine, CA. , , 2010.
  • Invited Speaker, Ballard Spahr, Salt Lake City, Utah. , , 2010.
  • Invited Speaker, Allergan, Inc., Irvine, CA. , , 2010.
  • Invited Speaker, Genentech, Inc., "Insights Into the Complement Pathway & Treatment of Age-related Macular Degeneration: A New Era", San Francisco, CA. , , 2010.
  • Invited Speaker, Sequenom, Inc., "A New Era for Age-related Macular Degeneration: Biological and Therapeutic Insights, San Diego, CA. , , 2010.
  • Chair, Sequenom, Inc., Clinical Advisory Board. , , 2010.
  • Invited Speaker, Taligen Therapeutics, "A New Formula for Therapeutic Development: Strategic Translational Partnership, San Francisco, CA. , , 2009.
  • Invited Speaker, Allergan, Inc., "A New Era for Therapeutic Development: Strategic Translational Partnership, Irvine, CA. , , 2009.
  • Member, Alcon Research Institute. , , 2009.
  • Facilitator, Genentech, Inc., BioRetina Summit, "Immune-mediated Processes in AMD", Genentech, San Francisco CA. , , 2009.
  • Invited Speaker, Merck Pharmaceuticals, "Aberrant Regulation of the Complement System in Age-related Macular Degeneration", Radnoor, PA. , , 2007.
  • Invited Speaker, Pfizer Inc., "An Overview of the Pathobiology & Genetics of AMD", Pfizer PGRD, La Jolla, CA. , , 2006.
  • Speaker, Optherion, Inc., Optherion Series A Fundraising (and Other) Presentations: Quaker Bioventures (Boston); Alcon (Fort Worth); Pfizer SIG (New York City); Magnus Pearson (Sweden); SV Life Sciences (New York City); Kleiner Perkins Caufield & Byers (San Francisco); Flagship Ventures (Cambridge); L Capital Partners (New York City); MVM Life Science Partners (Boston); Advent International Corp. (Boston, MA); Johnson & Johnson Development Corp. (Radnor); Biogen Idec (Boston); Domain Associates (Princeton); A.M. Pappas and Associates (Research Triangle Park); Ortho Clinical Diagnostics (Raritan); CHL Medical Partners (Stamford); Venrock (New York City); ATV Ventures (Boston); Wellmark Investment Services (Des Moines); Corridor Management Company (Cedar Rapids); Aavin Venture Capital (Cedar Rapids); MVM Life Science Partners (Boston); Och-Ziff Capital (New York City); Quaker Bioventures (Boston); Radius Ventures (New York City); SR-One (Philadelphia); SV Life Sciences (Boston); Venrock Associates (New York City); Allergan, Inc. (Irvine, CA); Correlagen Diagnostics (Waltham, MA); Stem Cell Sciences (London, U.K.); Shire Pharmaceuticals (Boston); Sequenom (San Diego). , , 2006.
  • Invited Speaker & Advisor, Taligen Therapeutics, "Aberrant Complement Activation in AMD", Aurora, CO. , , 2006.
  • Presenter, Optherion, Inc., Optherion Presentations: Quaker Bioventures (Boston), Alcon (Fort Worth), Pfizer SIG (New York City), Magnus Pearson (Sweden), SV Life Sciences (New York City), Kleiner Perkins Caufield & Byers (San Francisco), Flagship Ventures (Cambridge), L Capital Partners (New York City), MVM Life Science Partners (Boston), Advent International Corp. (Boston, MA), Johnson & Johnson Development Corp. (Radnor), Biogen Idec (Boston), Domain Associates (Princeton), CHL Medical Partners (Stamford), Venrock (New York City), ATV Ventures (Boston), Wellmark Investment Services (Des Moines), Corridor Management Company (Cedar Rapids), Aavin Venture Capital (Cedar Rapids), MVM Life Science Partners (Boston), Och-Ziff Capital (New York City), Quaker Bioventures (Boston), Radius Ventures (New York City), SR-One (Philadelphia), SV Life Sciences (Boston), Venrock Associates (New York City), Allergan, Inc. (Irvine, CA), Correlagen Diagnostics (Waltham, MA) Stem Cell Sciences (Longon, U.K.) Shire Pharmaceuticals (Boston), Seuqenom (San Diego, CA). , , 2006.
  • Invited Speaker, TargeGen, Inc., "Aberrant Complement Regulation in Age-related Macular Degeneration", TargeGen Scientific Advisory Board Meeting, San Diego, CA. , , 2006.
  • Invited Speaker, Archemix Corporation, "AMD: A Disease of Aberrant Complement Regulation?", Boston, MA. , , 2006.
  • Invited Speaker, Genentech, Inc., “The Role of Immune-mediated Pathways in Age-related Macular Degeneration”, South San Francisco, CA. , , 2005.
  • Invited Speaker, ParAllele Biosciences Inc., “A Common Haplotype in the Complement Regulatory Gene, Factor H (HF1/CFH), Predisposes Individuals to Age-related Macular Degeneration”, San Francisco, CA. , , 2005.
  • Invited Speaker, ParAllele Biosciences Inc., "Discovery of Pathways and Targets Associated with Age-related Macular Degeneration", South San Francisco CA. , , 2005.
  • Invited Speaker, Alcon Laboratories, "Insights into the Biology of Choroidal Neovascularization", Alcon Laboratories Retina Expert Advisory Meeting, Dallas TX. , , 2004.
  • Invited Speaker, Eyetech Inc., “Characterization of Targets for the Treatment of AMD”, Boston, MA. , , 2003.
  • Invited Speaker, Pharmacia Ophthalmics, “Initiative for Discovery of Druggable Targets for Age-related Macular Degeneration”, St. Louis, MO. , , 2003.
  • Invited Speaker, Pfizer Inc., Pfizer Global Research and Development. “Discovery of Targets Associated with AMD”, La Jolla, CA. , , 2003.
  • Invited Speaker, Pharmacia Ophthalmics, "Use of Human Donor Tissues to Characterize Pathways Associated with Human Ocular Disease", St. Louis, MO. , , 2002.
  • Invited Speaker, Alcon Laboratories, "Use of Human Donor Tissues to Characterize Pathways Associated with Human Ocular Disease", Ft. Worth, TX. , , 2002.
  • Invited Speaker, Bristol-Myers Squibb, "Pathways Involved in the Etiology of Age-Related Macular Degeneration", Princeton, NJ. , , 2001.
  • Invited Speaker, Novartis Pharmaceuticals Corporation, “A Proposed Role for Dendritic Cells in Age-Related Macular Degeneration”, Vienna, Austria. , , 2001.
  • Invited Speaker, Novartis Pharmaceuticals Corporation, "The University of Iowa Interdisciplinary Research Program in AMD", Novartis Research Advisory Board, Basel, Switzerland. , , 2000.
  • Presenter, Novartis Pharmaceuticals Corporation, "Interdisciplinary Research Program in AMD", Novartis Research Advisory Board, Basel, Switzerland. , , 1999.
  • Invited Speaker, Warner-Lambert, "Insights Into the Pathobiology of AMD", Agouron/Warner-Lambert Pharmaceuticals, San Diego. , , 1999.
  • Guest Speaker, Alcon Laboratories, "Recent Insights into the Pathogenesis of Age-Related Macular Degeneration", Fort Worth, TX. , , 1998.
  • Presenter, Alcon Laboratories, "Overview of AMD and Tears Research Programs" Alcon Laboratories, Storz Ophthalmics, CibaVision, Iolab Corporation, and Allergan. , , 1994.
  • Invited Speaker, American Cyanamid Company, “Chondroitinase Assisted Vitreous Disinsertion,” Chondroitinase Clinical Development Meeting, Southampton, Bermuda. , , 1993.
  • Invited Speaker, American Cyanamid Company, "Enzymatic Disinsertion of the Primate Vitreous Body" and "Age-Related Macular Degeneration", American Cyanamid/Lederle Pharmaceuticals, Pearl River, NY. , , 1992.
  • Invited Speaker, American Cyanamid Company, "Sequestration of Basic Fibroblast Growth Factor in the Interphotoreceptor Matrix: Pharmaceutical Potential," Pearl River, NY. , , 1990.
  • Invited Speaker, American Cyanamid Company, "Characterization of the Vitreoretinal Interface and Retinal Adhesion," Pearl River, NY. , , 1989.
  • Invited Speaker, Storz Instrument Company, "Retinal Attachment and Detachment" and "Preliminary Observations of Epithelial Outgrowth from Corneal Explants onto Coated Synthetic Surfaces," St. Louis, MO. , , 1989.
  • Invited Speaker, American Cyanamid Company, "Enzymatic Disinsertion of the Primate Vitreous Body," American Cyanamid/Lederle Pharmaceuticals, Pearl River, NY. , , 1989.
  • Invited Speaker, "The Moran Center for Translational Medicine: Toward the Development of Therapies for Age-related Macular Degeneration," AST Meeting, John A. Moran Eye Center, Salt Lake City, Utah. , , 2014.
  • Keynote Speaker, "Can genetics provide the answer to optimal wet AMD treatment?" John A. Moran Eye Center, University of Utah. , , 2014.
  • Invited speaker, "Partnership to Identify Pathways and Targets Associated with Diabetic Retinopathy," NovoNordisk, Copenhagen. , , 2014.
  • Invited speaker, "Can genetics provide the answer to optimal wet AMD treatment?" World Ophthalmology Congress, Tokyo, Japan. , , 2014.
  • Invited speaker, "Towards a deeper understanding of wet AMD therapy: optimizing benefits, managing risks and individualizing care," World Ophthalmology Congress, Tokyo, Japan. , , 2014.
  • Invited speaker, "Toward a Refined Understanding of the Genetics & Biology of Age-related Macular Degeneration," Macula Vision Research Foundation Conference, Atlanta, Georgia. , , 2014.
  • Invited speaker, "Research and early development projects, academic and industry perspectives," Vision Research Day, Zurich, Switzerland. , , 2014.
  • Keynote Speaker, 'The Moran Center for Translational Medicine: Toward the Development of Therapies for Age-related Macular Degeneration,' Murray Rotary Club, Cottonwood Country Club, Utah. , , 2014.
  • Invited Speaker, "Diagnostics & Therapeutics for AMD," North Star Optometry Seminars 2014, John A. Moran Eye Center, Salt Lake City, Utah. , , 2014.
  • Invited Speaker, 'Toward a Refined Understanding of the Genetics & Biology of Age-related Macular Degeneration,' North Star Optometry Seminar, Salt Lake City, Utah. , , 2014.
  • Invited Speaker, 'The Moran Center for Translational Medicine: Toward the Development of Therapies for Age-related Macular Degeneration,' Moran Donor Meeting, The Vintage Club, Indian Wells, California. , , 2014.
  • Invited Speaker, 'Gene markers and prevention - over the horizon or here today?' American Academy of Ophthalmology Meeting, New Orleans, Louisiana. , , 2013.
  • Invited Speaker, 'Toward a Refined Understanding of the Genetics & Biology of Age-related Macular Degeneration,' DiaxonHit & Allergan, Inc, Paris, France. , , 2013.
  • Invited Speaker, "Moran's CTM: Toward the Development of Diagnostics & Therapeutics for Age-related Macular Degeneration," TQM Meeting, John A. Moran Eye Center, Salt Lake City, Utah. , , 2013.
  • Resident lecture, "Structure, Function & Pathology of the Choroid-RPE-Retina-Vitreous Complex," John A. Moran Eye Center, Salt Lake City, Utah. , , 2013.
  • Invited Speaker, "Toward a Refined Understanding of the Biology & Genetics of Age-related Macular Degeneration," R24 Outcomes Meeting, National Eye Institute, Bethesda, Maryland. , , 2013.
  • "Pathology, Genetics, Diagnostics and Treatment of Eye Diseases", Tarto, Estonia. , , 2013.
  • Invited Speaker, "Toward a Refined Understanding of Age-related Macular Degeneration: A New Era," European Society of Ophthalmology, Copenhagen, Denmark. , , 2013.
  • Invited Speaker, "Toward a Refined Understanding of the Biology & Genetics of AMD: Therapeutic & Diagnostic Implications," Department of Biochemistry, Research in Progress Seminar, University of Utah. , , 2013.
  • Invited Speaker, "Toward a Refined Understanding of Age-related Macular Degeneration: Therapeutic and Diagnostic Implications", University of Utah Health Sciences Council, University of Utah, Salt Lake City, Utah. , , 2013.
  • Resident Retina Lecture, Anatomy of the Eye, John Moran Eye Center, University of Utah. , , 2013.
  • Visiting Professor, “Toward a Refinied Understanding of the Biology and Genetics of AMD: Therapeutic and Diagnostic Implications.”, University of California Los Angeles, Los Angeles. , , 2013.
  • Invited Speaker, "Toward the Development of Therapeutics & Diagnostics for AMD & Its Co-segregating Diseases," Universite Paris Descartes, Centre des Cordeliers, Paris, France. , , 2013.
  • Invited Speaker, "Toward a Refined Understanding of the Biology of Age-related Macular Degeneration Through Genetic Analyses," La Retine: Controverses en 2012, Universite Paris Descartes, Paris, France. , , 2013.
  • Invited Speaker, "Toward a Refined Understanding of the Biology & Genetics of AMD: Therapeutic & Diagnostic Implications," Angiogenesis, Exudation & Degeneration 2013, Miami, Florida. , , 2013.
  • Invited Speaker, "The Genetics of AMD", Retina Conference, University Paris Descartes, Paris, France. , , 2013.
  • Invited Speaker, "Unique Angiographic Characteristics Associated with Reticular Psuedodrusen," Fluorescein Conference, Centre for Eye Research Australia, Melbourne, Australia. , , 2012.
  • Invited Speaker, University Paris Descartes, Paris, France. , , 2012.
  • Invited Speaker, "Toward the Development of Diagnostics & Therapeutics Targeting Age-related Macular Degeneration: A New Era," Royal Victoria Hospital, Belfast, Northern Ireland, UK. , , 2012.
  • Invited Speaker, Royal Victoria Hospital, Belfast, Northern Ireland. , , 2012.
  • Invited Speaker, "Toward the Development of Diagnostics and Therapeutics Targeting Age-related Macular Degneration and Its Co-segregating Diseases: A New Era", 15th Samsung Macula Symposium, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. , , 2012.
  • Invited Speaker, Emeritus Hospital Board, University of Utah, Salt Lake City, Utah. , , 2012.
  • Invited Speaker, "A New Era: Diagnostics and Therapeutics Targeting AMD and Its Co-segregating Diseases", Alliance for Eye and Vision Research's Decade of Vision 2010-2020 Initiative a Congressional Briefing, House Rayburn, United States Congress, Washington, D.C. , , 2012.
  • Invited Speaker, "Genotype Correlation - Biology - Phenotype", AMD Phenotyping Committee Meeting, Arnold and Mabel Beckman Initiative for Macular Research, Newport Beach, CA. , , 2012.
  • Invited Speaker, Utah Legislature-Health and Human Services Committee, Salt Lake City, Utah. , , 2012.
  • Invited Speaker, "Toward a Refined Understanding of the Genetics & Biology of Age-related Macular Degeneration", National Eye Institute, NIH, Washington, DC. , , 2012.
  • Invited Speaker, "Toward a Refined Understanding of the Genetics, Biology and Treatment of Age-related Macular Degeneration", Schepens Eye Research Institute, Boston, MA. , , 2012.
  • Invited Speaker, "Concepts Relating to the Biology of Age-related Macular Degeneration", Beckman Initiative for Macular Research, Irvine, California. , , 2012.
  • Moderator, Arnold and Mabel Beckman Initiative for Macular Research Conference, Newport Beach, CA. , , 2012.
  • Invited Speaker, "Toward the Development of Therapeutics & Diagnostics for Age-related Macular Degeneration and its Co-segregating diseases", Clinical Faculty Day, John Moran Eye Center, Department of Ophthalmology, University of Utah, Salt Lake City, Utah. , , 2011.
  • Invited Speaker, ARVO-NED, Utrecht, Netherlands. , , 2011.
  • Invited Participant, Erasmus University Medisch Centrum, Ophthalmology-Epidemiology-Genetics, Rotterdam, Netherlands. , , 2011.
  • Invited Speaker, "Toward the Development of Therapeutics and Diagnostics for AMD and Co-segregating Deisease", Willard Eccles Foundation, University of Utah, Salt Lake City, Utah. , , 2011.
  • Invited Speaker, Private Eye Center, Shiraz, Iran. , , 2011.
  • Invited Speaker, Private Eye Center, Tehran, Iran. , , 2011.
  • Invited Speaker, "A New Era in Our Understanding of the Genetics and Biology of Age-related Macular Degneration", Molecular & Human Genetics Seminar Series, Baylor College of Medicine, Department of Molecular & Human Genetics, Genome Sequencing Center, Houston, Texas. , , 2011.
  • Moderator, Arnold and Mabel Beckman Initiative for Macular Research Conference, Newport Beach, CA. , , 2011.
  • Keynote Speaker, "A New Era in Our Understanding of Age-related Macular Degeneration", Robert B. Barlow Distinguished Lecture in Vision, State University of New York, Upstate Medical University. , , 2010.
  • Invited Speaker, "Age-related Macular Degeneration: The End is in Sight", Health Sciences Council, University of Utah, Utah. , , 2010.
  • Invited Speaker, "Age -related Macular Degeneration: The End is in Sight", Educational Resource Development Council, John Moran Eye Center, University of Utah, Utah. , , 2010.
  • Invited Speaker, "A New Era in Our Understanding of Age-related Macular Degeneration", Moran Eye Center Research In-Sights, John Moran Eye Center, University of Utah, Utah. , , 2010.
  • Invited Speaker, Modulation of Visual Sensitivity Minisymposium Honoring Robert B. Barlow, Jr ARVO, Ft. Lauderdale, FL. , , 2010.
  • Moderator, Arnold and Mabel Beckman Initiative for Macular Research Conference, Newport Beach, CA. , , 2010.
  • Invited Speaker, “Insights Pertaining to the Role of the Complement System in Age-related Macular Degeneration”, Macular Vision Research Foundation Conference, Washington, DC. , , 2009.
  • Invited Speaker, "A New Era for Age-related Macular Degeneration: Biological and therapeutic Insights", Microbial Pathogenesis Seminar Series, Department of Pathology, University of Utah, Utah. , , 2009.
  • Invited Speaker, "Insights Into the Biology & Genetics of Age-related Macular Degeneration: A New Era", The Latest in Vision Research Annual Update, John Moran Eye Center, University of Utah, Utah. , , 2009.
  • Invited Speaker and Moderator, “Rapid-fire Posters Overview”, Ophthalmic Drud Delivery Systems for the Treatment of Retinal Diseases, ARVO/NEI 2009 Summer Eye Research Conference, Bethesda, MD. , , 2009.
  • Invited Participant, Arnold and Mabel Beckman Initiative for Macular Research Conference, Newport Beach, CA. , , 2009.
  • Invited Science Panel Member and Speaker, “Age-related Macular Degeneration: Pathways & Genetics”, AMD Alliance International Science Panel, Paris, France. , , 2009.
  • Invited Guest Speaker, “A New Era for Age-related Macular Degeneration: Biological & Therapeutic Insights”, New Advances in Genetics & Retinal Transplantation, First Retinal Science Day, Ludwig Boltzmann Institute for Retinology & Biomicroscopic Laser Surgery, Vienna, Austria. , , 2009.
  • Invited Speaker, “A New Era for Age-Related Macular Degeneration: Insights Pertaining to a Key Role for the Complement System”, Moran Eye Center, Salt Lake City, Utah. , , 2008.
  • Invited Speaker, “What Can Age-related Macular Degeneration Teach Us About Dense Deposit Disease?” and “Toward Therapies for Age-related Macular Degeneration & Dense Deposit Disease”, Hinxton Conference of Excellence: Dense Deposit Disease Focus Group, Wellcome Trust Conference Centre, Hinxton, U.K. , , 2008.
  • Invited Speaker, “A New Era for Age-related Macular Degeneration: Insights Pertaining to a Key Role for the Complement System”, National Eye Institute, Bethesda, MD. , , 2008.
  • Invited Speaker, “Creating Partnerships Across Iowa in Economic Development: Toward the Development of Diagnostics & Therapeutics for Age-related Macular Degeneration”, Economic Development Appropriations Subcommittee, Supreme Court Chamber, State of Iowa Capitol Building, Des Moines, IA. , , 2008.
  • Invited Speaker, “Emerging Pathogenetic and Therapeutic Concepts”, Danish Immunological Society, Copenhagen Cluster of Immunology, & Graduate School of Immunology, The Panum Institute, University of Copenhagen, Denmark. , , 2008.
  • Invited Speaker, Guest Lecturer, “Aberrant Regulation of Complement in Age-related Macular Degeneration”, Lund University, Sweden. , , 2008.
  • Distinguished Lecture, “Aberrant Activity of the Complement System in Age-related Macular Degeneration”, Cole Eye Institute, Cleveland, OH. , , 2008.
  • Invited Speaker, “The Role of Inflammation and Gene Expression in Age-related Macular Degeneration”, Vision Research Conference, Department of Ophthalmology, The University of Michigan, Ann Arbor, MI. , , 2008.
  • Invited Guest Speaker, “Aberrant Complement Activation in Age-related Macular Degeneration”, Biomedicum Helsinki, University of Helsinki, Finland. , , 2007.
  • Invited Guest Speaker, “Genes & Pathways Associated with Age-related Macular Degeneration”, Vision Research and Imaging for the 21st Century, Department of Optometry, Cardiff, Wales. , , 2007.
  • Invited Speaker, “Aberrant Regulation of the Complement System in Age-related Macular Degeneration”, University of Pittsburgh, PA. , , 2007.
  • Student-nominated Guest Speaker, “Pathobiology and Pathways of Age-related Macular Degeneration and Related Diseases”, Department of Cell Biology, Neurobiology and Anatomy, Loyola University, Chicago, IL. , , 2007.
  • Special Seminar Invited Speaker, “Genetic Studies Reveal Insights into Aberrant Complement Activity in Age-related Macular Degeneration”, Division of Rheumatology, University of Colorado Health Sciences Center, Aurora, CO. , , 2007.
  • Invited Speaker, “The Role of Complement in Age-related Macular Degeneration”, University of Sydney, Australia. , , 2007.
  • Invited Faculty, Retinal Degeneration Symposium: Understanding the Causes and Finding the Cures, “Aberrant Complement Activation in Age-related Macular Degeneration”, The University of Utah, Department of Ophthalmology & Visual Sciences, John A. Moran Eye Center, Salt Lake City, UT. , , 2006.
  • Invited Speaker and Participant, Hinxton MPGN II Focus Group Retreat, “The Genetics of AMD - Can we Learn Something about MPGN II?”, Hinxton, U.K. , , 2006.
  • Guest Faculty, Foundation Fighting Blindness, “Macular Degeneration: Breakthroughs and Beyond”, Angeles, CA. , , 2006.
  • Invited Speaker, “A Role for Complement-mediated pathways in AMD”, Macula Vision Research Foundation Conference, Charleston, South Carolina. , , 2005.
  • Invited Speaker, “The Role of the Complement System in the Etiology of Age-related Macular Degeneration”, Macular Degeneration and Complement Factor H Symposium, National Eye Institute. , , 2005.
  • Visiting Speaker, “Role of the Complement System in Age-related Macular Degeneration”, Washington University, St. Louis, MO. , , 2005.
  • Invited Speaker, “A Common Haplotype in the Complement Regulatory Gene, Factor H (HF1/CFH), Predisposes Individuals to Age-related Macular Degeneration", Steinbach Fund, New York. , , 2005.
  • Invited Speaker, “Discovering the Genetic Basis of Age-related Macular Degeneration”, Capitol Hill Briefing, AVER, Washington, D.C. , , 2005.
  • Visiting Speaker, “Role of the Complement Pathway in Age-related Macular Degeneration”, OSHU, Portland, OR. , , 2005.
  • Invited Participant and Speaker, “What Can We Learn About Dense Deposit Disease in the Kidney by Studying Ocular Drusen?,” MPGN Type 2 Focus Group, Franklin W. Olin College of Engineering, Needham, MA. , , 2004.
  • Visiting Professor, “Pathways in the Etiology of Age-related Macular Degeneration”, Edward S. Harkness Eye Institute, Columbia University College of Physicians and Surgeons, New York. , , 2004.
  • Invited Speaker, “The Participation of Inflammation in Age-related Macular Degeneration”, University of Bonn, Germany. , , 2004.
  • Visiting Professor, “Evidence for a Role of Immune-mediated Processes in Age-related Macular Degeneration”, Washington University, St. Louis, Missouri. , , 2004.
  • Invited Speaker, “The Role of Inflammation in AMD”, Department of Microbiology, University of Iowa, Iowa. , , 2003.
  • Invited Faculty, “Is AMD an Inflammatory Disease?”, Baden-Baden, Germany. , , 2003.
  • Group Discussion Leader and Invite Participant, “AMD Cell Biology”, Workshop of the Deutsche Forschungsgemeinschaft Priority Research Program in AMD, Baden-Baden, Germany. , , 2003.
  • Invited Faculty, “Role of Antigen-presenting Cells in Age-related Macular Degeneration”, EU Antigen Presenting Cells in the Eye Workshop, Ettal, Germany. , , 2003.
  • Invited Faculty, “Evidence for the Participation of Inflammation and Immune-mediated Pathways in the Etiology of AMD”, Schepens International Society, Brugges, Belgium. , , 2003.
  • Visiting Scientist, “The Role of Immune-mediated Processes in Drusen Biogenesis and Age-related Macular Degeneration”, Schepen’s Retina Research Foundation/Harvard University. , , 2002.
  • Invited Speaker, “Biology of Macular Degeneration”, Washington Advisory Group, San Diego, California. , , 2002.
  • Invited Speaker, “Age-related Macular Degeneration”, DFG, Bonn, Germany. , , 2002.
  • Visiting Professor, University of Pittsburgh Department of Ophthalmology, Pittsburgh, Pennsylvania. , , 2001.
  • UICMD Board of Directors, “The Potential Role of Systemic Disease Processes in the Pathogenesis of Age-Related Macular Degeneration”. , , 2001.
  • First Annual Optometric Conference, University of Iowa Department of Ophthalmology and Visual Sciences. , , 2001.
  • Invited Speaker, "The Participation of Immune-Associated Pathways in the Development of Age-Related Macular Degeneration”, National Eye Institute, Bethesda, Maryland. , , 2001.
  • The University of Iowa Center on Aging, “Insights into the Biology, Genetics and Pathogenesis of Age-Related Macular Degeneration”. , , 2000.
  • Invited Speaker, “Drusen: Biomarkers of Immunomodulatory Processes Occurring at the RPE-Bruch’s Membrane Interface”, Macular Vision Research Foundation Conference, New Orleans. , , 2000.
  • The University of Iowa Molecular Biology Workshop, “Age-Related Macular Degeneration: Insights into the Role of Immune Mediated Events in its Pathogenesis”. , , 2000.
  • Visiting Professor, “Pathways Involved in the Etiology of Age-Related Macular Degeneration”, University of California Los Angeles, Los Angeles. , , 2000.
  • Invited Faculty, “Participation of Immune-Mediated Events in Drusen Biogenesis and Age-Related Macular Degeneration”, Canadian RP Foundation Vision Quest 2000: 11th World Congress of Retina International, Toronto. , , 2000.
  • Invited Speaker, “Bruch’s Membrane – A Barrier of Central Importance”, Symposium Aktueller Stand der Grundlagenforschung: Makuladegeneration, Deutschen Ophthalmologischen Gesellschaft, Berlin, Germany. , , 2000.
  • Visiting Professor, Visiting Scholars Program, University of Alabama-Birmingham. , , 2000.
  • Invited Speaker, “Genes, Molecules, Morphology, and Pathogenesis of AMD”, Inaugural Davson Lecture/Allergan Symposium, The Royal Society of Medicine, London. , , 2000.
  • Invited Faculty, “Ocular Genomcis: The Retina and Age-Related Macular Degeneration”, Ocular Genomics and Proteomics Conference, UNT Health Science Center/Alcon Research, Ft. Worth, Texas. , , 2000.
  • Invited Participant and Speaker, "Drusen Biogenesis”, Research to Prevent Blindness AMD Brainstorming Meeting, Washington D.C. , , 2000.
  • Invited Speaker, “Pathoglogic Changes in the rd6 Mouse Eye”, Jackson Laboratory. , , 1999.
  • Invited Participant, “An Integrated Hypothesis for Drusen Biogenesis”, Steinbach Fund, New York. , , 1999.
  • The University of Iowa Center on Aging, “Insights into the Biology, Genetics and Pathogenesis of Age-Related Macular Degeneration”. , , 1999.
  • Invited Speaker, ”RPE Cell Density in Age-Related Macular Degeneration”, Macular Vision Research Foundation Conference, Scottsdale, Arizona. , , 1999.
  • Invited Speaker, “The Composition and Biogenesis of Ocular Drusen”, Baden-Baden, Germany. , , 1999.
  • Invited Speaker, “Cellular and Molecular Insights into the Etiology of Age-Related Macular Degeneration”, Universite Louis Pasteur, Strasbourg, France. , , 1999.
  • Invited Speaker, “Recent Insights Pertaining to the Pathobiology and Etiology of Age-Related Macular Degeneration”, Iowa Optometry Meeting. , , 1999.
  • Invited Speaker, “Cellular and Molecular Insights into the Etiology of Age-Related Macular Degeneration”, Jackson Laboratory. , , 1998.
  • Invited Speaker, “Gene Expression in Age-Related Macular Degeneration”, Milton and Ruth Steinbach Foundation meeting, New York, New York. , , 1998.
  • Invited Speaker, “Cellular and Molecular Insights into the Etiology of Age-Related Macular Degeneration”, University of Iowa, College of Pharmacy, Medicinal and Natural Products Seminar, Iowa City, Iowa. , , 1998.
  • Invited Speaker, “Recent Insights into the Pathogenesis of Age-Related Macular Degeneration”, Iowa Microscopy Society Fall Meeting, 25th Anniversary of the University of Iowa Central Microscopy Research Facility, The University of Iowa, Iowa City, Iowa. , , 1998.
  • Invited Participant, “Drusen Genesis and the Etiology of Age-Related Macular Degeneration”, Research to Prevent Blindness AMD Brainstorming Session, Washington, D.C. , , 1998.
  • Invited Speaker, "Identification of Molecular Candidates for AMD,” Macular Vision Research Conference, Fisher Island, Florida. , , 1997.
  • Visiting Professor, "Composition and Function of the IPM," University of Illinois-Chicago, Department of Ophthalmology and Visual Sciences, Chicago. , , 1997.
  • Invited Speaker, “Recent Advances in the Cell Biology of AMD,” Optometry Seminar Day, Anheuser-Busch Eye Institute, St. Louis University, St. Louis, Missouri. , , 1996.
  • Visiting Professor, “The Interphotoreceptor Matrix and its Involvement in Retinal Adhesion and Detachment”, “Age-Related Macular Degeneration: Recent Insights”, and “Chondroitinase-Assisted Disinsertion of the Vitreous and the Consequences of Iatrogenic PVD”, Queen’s University of Belfast, Department of Ophthalmology, Royal Victoria Hospital, Belfast, Northern Ireland. , , 1996.
  • Invited Delegate, “Analyses of the Molecular Constituents of Age-Related Extracellular Deposits,” The Bath Macular Workshop, Bath, England. , , 1996.
  • Visiting Professor, “Age-Related Changes in the Macula: New Insights” and “Identification of Candidate Molecules for Age-Related Macular Degeneration”, Moorfields Eye Hospital and the Institute of Ophthalmology, London, England. , , 1996.
  • Visiting Professor, "Chondroitinase-Assisted Vitrectomy and Consequences of Mechanically-induced Posterior Vitreous Detachment," University of Iowa, Department of Ophthalmology, Iowa City, Iowa. , , 1995.
  • Visiting Professor, "Ocular Drusen Share Molecular Constituents Common to Atherosclerotic, Elastotic and Amyloid Deposits," Washington University. , , 1995.
  • Visiting Professor, "Structure, Function and Pathology of the Primate Interphotoreceptor Matrix," Wake Forest University, Winston-Salem, North Carolina. , , 1995.
  • Visiting Professor, "Chondroitinase-Mediated Disinsertion of the Primate Vitreous" and "Composition, Function and Pathology of the Retinal Interphotoreceptor Matrix," Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland. , , 1994.
  • Invited Speaker, "Functions of the Primate Retinal Interphotoreceptor Matrix," Department of Biology, St. Louis University. , , 1993.
  • Visiting Professor, "Chondroitinase-Mediated Vitrectomy: A Technique for Complete Vitreous Disinsertion," University of Manchester, Manchester, England. , , 1993.
  • Invited Participant and Speaker, "Role of the Extracellular Matrix in Repair and Replacement of the Visual System," International Workshop on Repair and Replacement to Restore Sight, National Institutes of Health, Bethesda, Maryland. , , 1991.
  • Visiting Professor, “Localization of Fibroblast Growth Factor in Interphotoreceptor Matrix", University of California, Beckman Eye Research Center, San Francisco, California. , , 1990.
  • Visiting Professor, "The Interphotoreceptor Matrix: Biochemistry, Structure and Function," Vision Research Seminar Series: A New Decade, Tulane University, New Orleans, Louisiana. , , 1990.
  • Invited Speaker, "Funding Investigators' Innovative Research Through Industry: Product Feasibility Versus Product Development," Association of University Professors of Ophthalmology. , , 1990.
  • Visiting Professor, "Cone Photoreceptor Matrix Sheaths: Structure, Composition and Function," Department of Ophthalmology, University of Florida, Gainesville, Florida. , , 1989.
  • Visiting Professor, "Cone Photoreceptor Matrix Sheaths: Structure, Composition and Function," Bascom Palmer Eye Institute, University of Miami, Miami. , , 1989.
  • Invited Speaker, "Cone Matrix Sheaths: Putative Mediators of Retinal Adhesion," Missouri Ophthalmology Society, Inc., St. Louis, Missouri. , , 1989.
  • Invited Speaker, "Cell Biology of the Cone Matrix Sheath", Cell Biology of Vision Symposium, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas. , , 1989.
  • Visiting Professor, "The Molecular Environment Associated with Primate Cone Photoreceptors," University of California, Jules Stein Eye Foundation, Department of Ophthalmology, Los Angeles, California. , , 1988.
  • Visiting Professor, "Differential Rates of Photoreceptor Degeneration in Taurine Deficient Albino and Pigmented Rats," Stonybrook University, Department of Molecular Biology, Stonybrook, New York. , , 1988.
  • Visiting Professor, "The Molecular Environment Surrounding Cone Photoreceptors," Eye Research Institute of Retina Foundation, Harvard University, Boston, Massachusetts. , , 1988.
  • Visiting Professor, "Structure, Composition and Function of Primate Cone Photoreceptors," Neurosciences Research Institute, University of California, Santa Barbara, California. , , 1988.
  • Visiting Professor, "Structure, Composition and Function of Cone Photoreceptor Matrix Sheaths," Department of Internal Medicine, St. Louis University, School of Medicine, St. Louis, Missouri. , , 1988.
  • Visiting Professor, "Microenvironment Associated with Primate Cone Photoreceptors," St. Louis University, School of Medicine, Pediatric Research Institute, St. Louis, Missouri. , , 1988.
  • Visiting Professor, "Cone Photoreceptor Matrix Sheaths: Unique Domains of Interphotoreceptor Matrix Surrounding Primate Cone Photoreceptors," Washington University, School of Medicine, Department of Ophthalmology, St. Louis, Missouri. , , 1987.
  • Visiting Professor, "Association of Glycosaminoglycans and Immunoglobulins with Primate Cone Photoreceptor Matrix Sheaths," St. Louis University, School of Medicine, Department of Internal Medicine, Division of Arthritis and Immunology, St. Louis, Missouri. , , 1987.
  • Visiting Professor, "Molecular Microenvironment of Primate Cone Photoreceptors," Emory University, School of Medicine, Department of Anatomy and Cell Biology, Atlanta, Georgia. , , 1987.
  • Visiting Professor, "Characterization of the Microenvironment Associated with Primate Cone Photoreceptors," St. Louis University, School of Medicine, Department of Pharmacology, St. Louis, Missouri. , , 1987.
  • Visiting Professor, "Novel Substructural and Biochemical Characteristics of Primate Cone Photoreceptors," University of Louisville School of Medicine, Departments of Biochemistry and Anatomy, Louisville, Kentucky. , , 1986.
  • Visiting Professor, "Novel Observations of Primate Cone Photoreceptors," Harvard Medical School, Berman-Gund Laboratory for the Study of Retinal Degenerations, Boston, Massachusetts. , , 1985.
  • Visiting Professor, "Early Ultrastructural Abnormalities in Retinae of Taurine Deficient Rats and Cats," Harvard Medical School, Berman-Gund Laboratory for the Study of Retinal Degenerations, Boston, Massachusetts. , , 1985.
  • Visiting Professor, "Lectin-binding Glycoproteins in the Vertebrate Vitreous Body and Inner Limiting Membrane: Tissue Localization and Biochemical Characterization," Doheny Eye Institute, Department of Ophthalmology, Los Angeles, California. , , 1984.
  • Visiting Professor, "Ultrastructural Analysis of Compartmentalization in the Vertebrate Ocular Uveal Tract: Putative Implications for Uveoscleral Outflow and Retinal Maintenance," Harvard Medical School, Department of Ophthalmology, Boston, Massachusetts. , , 1984.
  • Visiting Professor, "Cone Photoreceptor-specific Binding of Peanut Lectin in the Vertebrate Retina: Morphological Localization and Biochemical Characterization," Harvard Medical School, Department of Ophthalmology, Boston, Massachusetts. , , 1984.
  • Visiting Professor, "Fine Structural Analysis of Compartmentalization in the Hamster Uvea: Implications for Aqueous Humor Outflow," Agnes Scott College, Department of Biological Sciences, Atlanta, Georgia. , , 1983.
  • Visiting Professor, "Ultrastructural Aspects of Oogenesis and Accessory Reproductive Structures in the Marine Bryozoan Membranipora serrilamella," California State University Dominquez Hills, Department of Biology, Los Angeles, California. , , 1982.
  • Visiting Professor, "Oogenesis and Gamete Release in a Marine Bryozoan," University of Southern California School of Medicine, Department of Anatomy, Los Angeles, California. , , 1981.
  • Keynote speaker, "Genotype-phenotype correlation in AMD," Coimbra Ophthalmology International Congress, Coimbra, Portugal. , , 2014.
  • Keynote speaker, "Are there more forms of AMD than wet and dry?" International Congress of German Ophthalmic Surgeons, Nurnberg, Germany. , , 2014.
  • Keynote speaker, "Toward a deeper understanding of wet AMD therapy: optimizing beneifts, managing risks and individualizing care." Novartis-sponsored symposium at World Ophthalmology Congress 2014, Tokyo, Japan. , , 2014.
  • Keynote Speaker, 'Toward a Refined Understanding of the Biology & Genetics of Age-related Macular Degeneration,' Elizabeth Thomas Seminar (Pre-Meeting), Nottingham, England. , , 2013.
  • Keynote Speaker, "Age-related Macular Degeneration: Overview, Pathology & the Complement Pathway," Pathology, Genetics, Diagnostics & Treatment of Eye Diseases, Tartu, Estonia. , , 2013.
  • Keynote Speaker, "Toward a Refined Understanding of Age-related Macular Degeneration: A New Era," Pathology, Genetics, Diagnostics and Treatment of Eye Diseases, Tartu, Estonia. , , 2013.
  • Keynote Speaker, "Age-related Macular Degeneration: Reticular Pseudodrusen & Therapeutic Development," Pathology, Genetics, Diagnostics & Treatment of Eye Diseases, Tartu, Estonia. , , 2013.
  • Keynote Speaker, "Toward the Development of Therapeutics & Diagnostics for Age-related Macular Degeneration & Its Co-segregating Diseases", European Society of Ophthalmology, Copenhagen, Denmark. , , 2013.
  • Invited Speaker, "Biology, Genetics and Pathways Associated with Age-related Macular Degeneration: A New Era", Challenge in AMD Study 2012 Beijing, Beijing, China. , , 2012.
  • Keynote Speaker, "Toward a Refined Understanding of Age-related Macular Degeneration: A New Era", Gifford Lecturer, Gifford-Truhlsen Residents and Alumni Day, University of Nebraska Medical Center, Omaha, Nebraska. , , 2012.
  • Keynote Lecture, "Toward a Refined Understanding of the Genetics, Biology & Treatment of Age-related Macular Degeneration", Distinguished Lecture, Schepens Eye Research Insstitute, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts. , , 2012.
  • Invited Speaker and Award Recipient, "The Pathogenesis, Genetics, Diagnosis & Treatment of Age-related Macular Degeneration: Entering a New Era", Lighthouse International Pisart Vision Award, New York City, NY. , , 2012.
  • Keynote Speaker, "A New Era in Our Understanding of Age-related Macular Degeration", European Society of Ophthalmology, Geneva, Switzerland. , , 2011.
  • Invited Guest Lecturer, "Complement and AMD", The New York Retina Club, New York, NY. , , 2011.
  • Keynote Speaker, Iranian Reseach Association for Vision and Ophthalmology-Iranian Vitreoretina Society-Ophthalmic Research Center, Tehran, Iran. , , 2011.
  • Keynote Speaker, " A New Era in Our Understanding of the Biology, Diagnosis, and Treatment of ARMD", Utah Ophthalmology Society, Deer Valley, Utah. , , 2011.
  • Keynote Speaker, Iranian Reseach Association for Vision and Ophthalmology-Iranian Vitreoretina Society-Ophthalmic Research Center, Tehran, Iran. , , 2011.
  • Keynote Speaker, "A New Era in Our Understanding of Ahe-related Macular Degeneration", LuEsther T. Mertz Vitreous Retina Macula Lectureship, Manhattan Eye, Ear, & Throat Institute of Lenox Hill Hospital. , , 2010.
  • Keynote Speaker, "A New Era in our Understanding of Age-related Macular Degeneration", Retina 2010, Dublin, Ireland. , , 2010.
  • Plenary Lecture, A New Era in Our Understanding of Age-related Macular Degeneration, RD2010, Montreal, Canada. , , 2010.
  • Plenary Lecture, "A New Era for Age-related Macular Degeneration: Biological & Therapeutic Insights", Beaumont Hospital, Dublin, Ireland. , , 2010.
  • Keynote Lecture, “A New Era: Insights Pertaining to a Key Role for the Complement System in Age-related Macular Degeneration”, Deutsche Ophthalmologische Gesellschaft, Leipzig, Germany. , , 2009.
  • Plenary Speaker, Iowa Academy of Ophthalmology, Des Moines, IA. , , 2009.
  • F. Phinizy Calhoun Jr. Lecture, “A New Era for Age-related Macular Degeneration: Biological & Therapeutic Insights” Vision Research Seminar, Department of Ophthalmology, Emory University, Atlanta, GE. , , 2009.
  • Bradley R. Straatsma Lecture, “A New Era for Age-related Macular Degeneration: Biological and Therapeutic Insights”, Jules Stein Eye Institute, University of California Los Angeles, CA. , , 2009.
  • Keynote Speaker, “Age-Related Macular Degeneration and the Immune System”, FASEB Summer Research Conference, Vision Conference, The Biology and Chemistry of Vision, Snowmass, CO. , , 2009.
  • Ashton Eponymous Lecture, “A Role for Aberrant Complement Regulation in Age-related Macular Degeneration”, The Royal College of Ophthalmologists, 20th Anniversary Annual Congress, Liverpool, England. , , 2008.
  • Congressional Briefing, Featured Speaker, “New Developments into the Genetic Basis, Diagnosis & Treatment of Age-related Macular Degeneration”, in recognition of AMD Awareness Week and on behalf of Alliance for Vision Eye Research, Association for Research in Vision and Ophthalmology, American Academy of Ophthalmology, Ad Hoc Group for Medical Research, Alliance for Aging Research, AMD Alliance International and Lighthouse International, Washington, D. C. , , 2008.
  • Plenary Speaker, “New Concepts on the Pathogenesis of AMD” and “The Future of AMD Research”, Retina Canada 2008 Meeting, Scottsdale, AZ. , , 2008.
  • Keynote Speaker, “Status of AMD Research”, The 9th International Conference on Low Vision “AMD Research”, Montreal, Canada. , , 2008.
  • Keynote Speaker, “A New Era for Age-Related Macular Degeneration: Insights Pertaining to a Key Role for the Complement System”, EVER Congress, Portoroz, Slovenia. , , 2008.
  • Keynote Speaker, “A New Era for Age-related Macular Degeneration: Insights Pertaining to a Key Role for the Immune System”, The Allergan Foundation Lecture Series in Modern Biology, University of California Irvine, Irvine, CA. , , 2008.
  • Joseph M. Bryan Lecture, “Aberrant Complement Activation and Regulation in Age-related Macular Degeneration” and “Drusen Biogenesis and Composition”, Duke University, NC. , , 2007.
  • Walter R. Stafford Alumni Lecture, “Aberrant Regulation of the Complement System in Age-related Macular Degeneration”, St. Louis University Eye Institute, St. Louis, MO. , , 2007.
  • Plenary Speaker, “Aberrant Complement Activation and Regulation in Age-related Macular Degeneration”, 39th Annual Scientific Congress of the Royal Australian & New Zealand College of Ophthalmologists, Perth, Australia. Other invited presentations: “Biology of Choroidal Neovascularization”, “Where Next for the Treatment of Early Stage Age-related Macular Degeneration” and “ Why the Macula?”, Perth, Australia. , , 2007.
  • Plenary Speaker, “Aberrant Control of the Complement System in Age-related Macular Degeneration”, XI European Meeting on Complement in Human Disease, Cardiff, Wales. , , 2007.
  • Keynote Lecture, “Pathways and Genes Associated with the Etiology of Age-related Macular Degeneration”, OccuLogix SAB Meeting, Ft. Lauderdale, FL. , , 2007.
  • Keynote Speaker, “The Role of Inflammation in Age-related Macular Degeneration”, Iowa Lions 9 x 9 District Convention, Iowa City, IA. , , 2006.
  • Roger H. Johnson Macular Degeneration Prize Lecture, “Age-related Macular Degeneration: A Disease of Aberrant Complement Regulation?”, University of Washington, Seattle, WA. , , 2006.
  • Keynote Speaker, “A Role for Abnormal Complement Regulation in Age-related Macular Degeneration”, New York Academy of Medicine, New York City, NY. , , 2006.
  • Keynote Address, “Role of Complement in Age-related macular Degeneration”, IBC 3rd International Conference on Ocular Anti-angiogenesis, Cambridge, MA. , , 2006.
  • Keynote Speaker and Visiting Faculty, “Altersbedingte Makulardegeneration und KomplementFaktor H”, Augenabteilung Krankenanstalt Rudolfstiftung/Ludwig Boltzmann Institut fur Retinologie und Biomikrosopische Laserchirurgie, Vienna, Austria. , , 2006.
  • Plenary Speaker, "Complex Genetic Disease" Plenary Session, British Human Genetics Conference, York, U.K. , , 2006.
  • 2005 Guest Faculty (Novartis sponsored), “Role of the Complement System in AMD” and “Common Pathways Shared by AMD and Alzheimer Disease”, University of Melbourne, Australia. , , 2005.
  • Elizabeth Thomas Seminar, “Role of the Complement System in Age-related Macular Degeneration, Nottingham, U.K. , , 2005.
  • Keynote Speaker, “The Role of Immune-mediated Pathways in the Etiology of Age-related Macular Degeneration”, CAE Academic Forum on Modern Biomedicine and the 6th Qindao International Symposium of Ophthalmology, Qingdao, China. , , 2004.
  • James A. Craig Lecture, “Assessing the Role of Inflammation in the Etiology of Age-related Macular Degeneration”, 6th Alumni Day Lecture, Queen’s University Belfast. , , 2003.
  • Keynote Speaker, “Role of Complement in Age-related macular Degeneration”, IBC Third International Conference on Ocular Angiogenesis, Cambridge, MA. , , 2003.
  • Keynote Speaker, "Toward the Characterization of Pathways Involved in the Etiology of Age-Related Macular Degeneration”, CIBA Vision Nordic Launch Meeting for Visudyne, Stockholm, Sweden. , , 2000.
  • Keynote Speaker, “AMD”, Lions International District 9X9 Fall Rally, Iowa City, Iowa. , , 2000.
  • Keynote Speaker, “Toward the Characterization of Pathways Involved in the Etiology of Age-Related Macular Degeneration: A Strategy Based upon the Use of Human Donor Eyes, Proteomics, and Gene Arrays Analyses”, Association for Research in Vision and Ophthalmology Sunday Symposium, Ft. Lauderdale, Florida. , , 2000.
  • Fondazione G.B. Bietti Award Lectures, Studio e la Ricerca in Oftalmologia Conference on Vitreoretinal Interface and Subretinal Space, Pontificia Universita Urbaniana, “Extracellular Matrix Biology”, “The Retina-RPE-Choroid Interface”, “Diseases of the Subretinal Space”, “Pharmacologic Vitreolysis”, and “The Pathogenesis of AMD”, Rome, Italy. , , 2000.
  • Sigma Xi 1997 Scientist of the Year, "Journeys in Retinal Cell Biology: From Basic Science to Clinical Applications", St. Louis University Chapter, St. Louis. , , 1997.
  • Keynote Speaker, "Age-Related Macular Degeneration and the Uses of Donor Tissue for Research" Mid America Transplant Services 1995 Annual Symposium, St. Louis, Missouri. , , 1995.
  • Jonathan Bok Memorial Lecture, “Structure, Function and Pathology of the Primate Interphotoreceptor Matrix”, Jules Stein Eye Institute, University of California Los Angeles, CA. , , 1994.
  • Alcon Visiting Professor, "Composition, Function and Pathology of the Retinal Interphotoreceptor Matrix," Emory University School of Medicine, Atlanta, Georgia. , , 1993.
  • Broadhurst Lecture, “The Molecular Environment Surrounding Cone Photoreceptors,” Eye Research Institute of Retina Foundation, Boston, MA. , , 1991.
  • Presented, 'Allergan-Voyant-Moran Center for Translational Medicine Collaboration: AMD & CTM Overview,' Research Meeting, University of Utah, Salt Lake City, Utah. , , 2014.
  • Presented, 'Update: Genetics, Biology & Clinical Aspects of Age-related Macular Degeneration,' Allergan, Inc., Irvine, California. , , 2013.
  • Meeting Presentation, "Update: Genetics, Biology & Clinical Aspects of Age-related Macular Degeneration," Sequenom, Inc., Salt Lake City, Utah. , , 2013.
  • "Toward a Refined Understanding of the Biology & Genetics of Age-Related Macular Degeneration," Applied Genetic Technologies, Corp., Chicago, Illinois. , , 2013.
  • Invited Speaker "Toward a Refined Understanding of the Bioogy & Genetics of AMD: Therapeutic & Diagnostic Implications.", Age-Related Macular Degeneration Scientific Input Engagement, Philadelphia, PA. , , 2013.
  • "Moran Center for Translational Medicine: Toward the Development of Diagnostics & Therapeutics for AMD," TQM Meeting, John A Moran Eye Center, Salt Lake City, Utah. , , 2013.
  • 'Toward the Development of Therapeutics & Diagnostics for AMD & Its Co-segregating Diseases," John A. Moran Eye Center, Advisory Board Meeting, Salt Lake City, Utah. , , 2013.
  • Moderator, Arnold and Mabel Beckman Initiative for Macular Research Conference, Newport Beach, CA. , , 2013.
  • Invited Speaker, "Phenotypic Variations in Dry AMD", Macula of Paris 2013, Paris, France. , , 2013.
  • Invited Speaker, "An Integrated Hypothesis of the Development and Progression of Age-related Macular Degeneration Based Upon Available Genetic and Biological Data", 62nd Annual Meeting of the American Society of Human Genetics, San Francisco, California. , , 2012.
  • Invited Speaker, "Toward a Refined Understanding of the Biology & Genetics of AMD: Therapeutic & Diagnostic Implications", 11th Macular Vision Research Foundation Conference, Chicago, Illinois. , , 2012.
  • Invited Speaker, "The Assessment of Pathways Involved in the Etiology of Age-related Macular Degeneration", NAKAMA, University of Utah, Salt Lake City, Utah. , , 2012.
  • Invited Speaker, "Clinical-Pathological Correlation in Patients with a History of Reticular Pseudodrusen", Arnold and Mabel Beckman Initiative for Macular Research, Newport Beach, CA. , , 2012.
  • Invited Speaker, Arnold and Mabel Beckman Initiative for Macular Research, Newport Beach, CA. , , 2012.
  • Invited Speaker, "Genotype Correlation-Biology-Phenotype", Arnold and Mabel Beckman Initiative for Macular Research, Newport Beach, CA. , , 2012.
  • Invited Speaker, Hope in Sight, John Moran Eye Center, Sun Valley, Idaho. , , 2012.
  • Invited Speaker, "Diagnostics & Therapeutics for Age-related Macular Degeneration: A New Era", 5th Annual FFB & Gavin Herbert Eye Institute Ophthalmic Innovations Symposium, Newport Beach, California. , , 2012.
  • Invited Speaker, John A. Moran Eye Center Interntional Advisory Council Meeting, University of Utah, Salt Lake City, Utah. , , 2012.
  • Invited Speaker, "The Genetics of Non-exudative Age-related Macular Degeneration", Macula 2012 Atlantic Coast Retina Club, New York City, NY. , , 2012.
  • Invited Speaker, "Drusen-Harbingers of AMD-associated Pathways and Genes", Macula of Paris 2012, Paris, France. , , 2012.
  • Invited Speaker, The Royal College of Ophthalmologists, Elizabeth Thomas Seminar, "Concepts in the pathogenesis of AMD", Nottingham, U.K. , , 2011.
  • Invited Speaker, "Preventing Irreversible Blindness: Closing in on a New Era of Treatments for Age-Related Macular Degeneration and its Related Diseases", University of Utah Health Sciences Advocates, Salt Lake City, Utah. , , 2011.
  • Invited Speaker, "Re-defining Age-related Macular Degeneration", Technology Commercialization and Innovation Program, Utah Govenor's Office of Economic Development, Salt Lake City, Utah. , , 2011.
  • Invited Speaker, "Toward the Development of Therapeutics and Diagnostics for AMD and Co-segregating Diseases", John A. Moran Eye Center Interntional Advisory Council Meeting, University of Utah, Salt Lake City, Utah. , , 2011.
  • Invited Speaker, "New Insights Into the Biology and Genetics of Age-related Macular Degeneration", International Conference on Complement Therapeutics, Rhodes, Greece. , , 2011.
  • Invited Speaker, John A. Moran Eye Center Interntional Advisory Council Meeting, University of Utah, Salt Lake City, Utah. , , 2011.
  • Invited Speaker, "Toward a Refined Understanding of Complement & Genetics in Age-related Macular Degeneration", AMD Alliance International, Scientific Advisory Panel, New York, New York. , , 2011.
  • Invited Speaker, John A. Moran Eye Center Interntional Advisory Council Meeting, University of Utah, Salt Lake City, Utah. , , 2011.
  • Invited Speaker, " Toward a Refined Understanding of the Genetics & Biology of Age-related Macular Degeneration", Alcon Research Institute Symposium, Fort Worth, Texas. , , 2011.
  • Invited Speaker,"The Moran Center for Translational Medicine: "Age-related Macular Degneration and Co-segregating Diseases as the Initial Target", University of Utah National Advisory Board, Salt Lake City, Utah. , , 2010.
  • Invited Speaker, "Inflammation and Complement in AMD”, Retina Subspecialty Day 2010: A Panretinal Perspective, American Academy of Ophthalmology, Chicago, IL. , , 2010.
  • Invited Speaker, John A. Moran Eye Center Interntional Advisory Council Meeting, University of Utah, Salt Lake City, Utah. , , 2010.
  • Invited Speaker, "Complement, Immune Responses and Age-related Macular Degeneration", 16th Retina International World Congress, Stresa, Italy. , , 2010.
  • Invited Speaker, “Therapeutic Targets for Geographic Atrophy in Age-related Macular Degeneration: Fundamental Aspects and Translation into New Treatment Paradigms”, ARVO SIG, Ft. Lauderdale, FL. , , 2010.
  • Invited Speaker, “A New Era for Age-related Macular Degeneration”, ARVO, Ft. Lauderdale, Florida. , , 2010.
  • Invited Speaker, "Complement Dysregulation in AMD", Macula of Paris 2010,Paris, France. , , 2010.
  • Invited Faculty and Speaker, “Complement-based Therapy in Age-related Macular Degeneration”, Angiogenesis, Exudation and Degeneration 2009, Key Biscayne, FL. , , 2009.
  • Invited Faculty and Speaker, Age-related Macular Degeneration: Genes, Pathways & Complement-based Therapies (Part I)”, Sarasota Retina Meeting, Sarasota, FL. , , 2009.
  • Invited Guest Speaker, “Aberrant Complement Activation in AMD”, Macula 2009 & Atlantic Coast Retina Meeting, New York City, NY. , , 2009.
  • State of Iowa Legislative, Economic Development, Board of Regents Delegation, “Toward the Treatment of Age-related Macular Degeneration: University of Iowa-Optherion Partnership”, Iowa City, IA. , , 2008.
  • Invited Faculty, “Aberrant Complement Regulation in Age-related Macular Degeneration“, Angiogenesis, Exudation and Degeneration Meeting, Bascom Palmer Eye Institute, Key Biscayne, FL. , , 2008.
  • Invited Speaker, “Local and Systemic Manifestations of Complement Activity in AMD”, Complement Factor H and Age-related Macular Generation SIG Meeting and “A Role for Aberrant Complement Regulation in Age-related Macular Degeneration”, AMD Symposium in Recognition of Peter Dudley, ARVO, Ft. Lauderdale, FL. , , 2008.
  • Invited Speaker, “Genetics of AMD and Implications for Treatment”, 1st Annual Retina Symposium, University of Illinois at Chicago, Chicago, IL. , , 2008.
  • Invited Speaker, “AMD – Pathogenesis and Treatment”, IV International Symposium of the German Ophthalmological Society, Baden Baden, Germany. , , 2007.
  • Invited Speaker, “Complement Factor H and Macular Degeneration”, Retina 2007: A View to the Future, American Academy of Ophthalmology, New Orleans, LA. , , 2007.
  • Invited Speaker, “Complement System in Ocular Health and Disease”, ARVO SIG “Immunity and the Aging Eye – Implications for Health and Disease”, Ft. Lauderdale, FL. , , 2007.
  • Visiting Faculty, “ARMD 2007: Optimizing Treatment for CNV”, Tufts University School of Medicine and New England Eye Center, Boston, MA. , , 2007.
  • Invited Speaker, “Age-related Macular Degeneration: A Disease Associated with Aberrant Complement Regulation”, Fourth International Workshop on Complement Associated Diseases, Porto Heli, Greece. , , 2007.
  • Invited Speaker, “Role of Inflammation in AMD”, ARVO SIG, Ft. Lauderdale, FL. , , 2006.
  • Invited Guest Speaker, “Role of the Complement Pathway in Age-related Macular Degeneration”, ISOCB, Cambridge, U.K. , , 2006.
  • Fight for Sight, “Update on Our Current Understanding of Age-related Macular Degeneration”, West Palm Beach and Mar-A-Lago, FL. , , 2006.
  • Guest Faculty and Invited Speaker, “Role of the Complement System in AMD”, UCSF “Tackling Early AMD: Devising New Strategies to Prevent Visual Loss” meeting, Sonoma, CA. , , 2005.
  • Presentation, Ruth Harkin, Iowa Board of Regents, “Toward Commercialization of Definitive Diagnostics and Therapeutics for Age-related Macular Degeneration”. , , 2005.
  • Guest Faculty, “Assessment of Pathways Associated with Age-related Macular Degeneration”, “Complement Activation in AMD: Insights from Other Diseases” and “Variation in Complement Factor H (CFH) Predisposes to AMD”, ERI Topics in Retinal Disease, Lake Louise, Alberta, Canada. , , 2005.
  • Invited Speaker, “RPE-Extracellular Matrix Interactions in Retinal Degeneration”, ARVO Minisymposium “Photoreceptor – RPE Interactions”, Ft. Lauderdale, FL. , , 2005.
  • Seminar Speaker, “Evidence for Inflammation in Age-related Macular Degeneration”, Interdisciplinary Program in Molecular Biology, University of Iowa. , , 2004.
  • Invited Faculty, “Inflammatory Response and its Therapeutic Consequences in AMD”, EVER Meeting, Vilamauri, Portugal. , , 2004.
  • Invited Speaker, “Obtaining Ocular Research Tissue”, ARVO Special Interest Group Meeting, Ft. Lauderdale, Florida. , , 2003.
  • Invited Speaker, “Characterization of Macular Soft Drusen”, ARVO Special Interest Group Meeting, Ft. Lauderdale, Florida. , , 2003.
  • Invited Speaker, “Is AMD an Inflammatory Disease?”, ARVO Special Interest Group Meeting, Ft. Lauderdale, Florida. , , 2003.
  • Invited Speaker, “Characterization of Pathways and genes involved in the etiology of age-related macular degeneration”, Second International Conference on Retinal Diseases and Glaucoma: New Therapeutic Strategies, The Knowledge Foundation, Miami, Florida. , , 2002.
  • Invited Speaker, “Role of Immune- and Inflammation-Associated Pathways in AMD”, Age-Related Macular Degeneration Symposium, University of Florida McKnight Brain Institute, Gainesville, Florida. , , 2002.
  • Invited Speaker, “Is Age-related Macular Degeneration an Inflammatory Disease?”, ARVO Special Interest Group Meeting, Ft. Lauderdale, Florida. , , 2002.
  • Invited Speaker, “Participation of Immune-associated Processes in AMD”, Oxford Ophthalmological Congress, Oxford, England. , , 2002.
  • Invited Speaker, “Topical Differences in the Structure and Composition of Bruch’s Membrane May Explain the Predilection of the Macula for Degeneration in Individuals with Age-related Macular Degeneration”, Second European Symposium: Elastin 2002, Acquafredda di Maratea, Italy. , , 2002.
  • Invited Speaker, “A Unified Hypothesis for the Biogenesis of Drusen” First International Symposium of the DRG Priority Research Program in Age-Related Macular Degeneration, Kloster Seeon, Munich, Germany. , , 2001.
  • Invited Speaker, “The Role of the RPE and Immune-Mediated Events in Age-Related Macular Degeneration”, European Union Meeting, The Retinal Pigment Epithelium (RPE) in Ageing, Disease and Therapy, Sintra, Portugal. , , 2000.
  • Invited Speaker, “The Role of RPE and Immune Mediated Events in Age-Related Maculopathy”, XXX Cambridge Ophthalmological Symposium, “Pathology of the Ageing Macula”, St. John’s College, Cambridge, England. , , 2000.
  • Invited Speaker, “Use of Chondroitinase during Vitrectomy Elicits Vitreous Disinsertion in Monkeys and Brain-Dead Humans”, Schepens International Symposium - Retina 1999: Dawn of a New Millennium, Jackson Hole, Wyoming. , , 1999.
  • Invited Speaker, 8th Biennial Western Eye Research Conference, Taos, New Mexico. , , 1999.
  • Invited Speaker, “Analyses of Differential Gene Expression in Age-Related Macular Degeneration” and “The Composition and Origin of Ocular Drusen and Basal Laminar Deposit”, Pathogenesis and Treatment of Age-Related Macular Degeneration Symposium, Johns Hopkins University. , , 1998.
  • Presentations, “Age Related Macular Degeneration and Other Eye Disease”, Cedar Rapids Medical Education Foundation Presentation to medical staff, St. Luke’s Hospital, Cedar Rapids, Iowa. , , 1998.
  • Invited Speaker, "Identification of Molecular Candidates for AMD: A Multidisciplinary Approach," 2nd International Symposium on Age-Related Macular Degeneration, Glasgow, Scotland. , , 1997.
  • Invited Speaker, “Application of Biotechnology Transfer to Retinal Disease”, Special Minisymposium, Association for Research in Vision and Ophthalmology, Ft. Lauderdale, Florida. , , 1997.
  • Invited Speaker, "Observations on the Ultrastructure and Development of Macular Extracellular Matrix Abnormalities", International EU Meeting on "Genetics of Macular Degeneration", Amsterdam, Netherlands. , , 1997.
  • Invited Guest Speaker, “Alterations of Bruch’s Membrane - A Favorite Site for Matrix Disease,” Zimmerman Lecture Symposium, American Academy of Ophthalmology, San Francisco, California. , , 1997.
  • Invited Speaker, “New Insights Into Drusen Composition and Structure”, University of Iowa, Iowa City, IA. , , 1996.
  • Invited Speaker, “Analyses of the Molecular Constituents of Age-Related Extracellular Deposits,” VII International Symposium on Retinal Degeneration, Sendai, Japan. , , 1996.
  • Invited Speaker, “Chondroitinase-Assisted Vitrectomy,” XII International Congress for Eye Research, Yokohoma, Japan. , , 1996.
  • Invited Faculty, “Retinal Histology Following Mechanically-induced Posterior Vitreous Detachments in Primates,” Suncoast Retina Research Forum, Sarasota, Florida. , , 1996.
  • Invited Speaker, "Cell Biology of Age-Related Macular Degeneration," ARVO Special Symposium, Ft. Lauderdale, Florida. , , 1996.
  • Speaker, “Cell Biological Approaches to Age-Related Macular Degeneration,” The University of Iowa College of Medicine, Howard Hughes Medical Institute Seminar Series, Iowa City, Iowa. , , 1996.
  • Invited Faculty, "Chondroitinase-Mediated Vitreous Disinsertion" Suncoast Retina Research Forum, Sarasota, Florida. , , 1995.
  • Speaker, "Ocular Drusen Share Molecular Constituents Common to Atherosclerotic, Elastotic and Amyloid Deposits," Anheuser-Busch Eye Institute Alumni Day, St. Louis University, St. Louis, Missouri. , , 1995.
  • Speaker, "Characterization of Ocular Drusen," Anheuser-Busch Eye Institute Alumni Day, St. Louis University, St. Louis, Missouri. , , 1994.
  • Invited Speaker, "Overview of Growth Regulators in Ocular Development, Survival and Pathology," Growth Factors Symposium, Association for Research in Vision and Ophthalmology, Sarasota, Florida. , , 1993.
  • Invited Speaker, "Cell Biology of Macular Degeneration," Age-Related Maculopathy Symposium, Association for Research in Vision and Ophthalmology, Sarasota, Florida. , , 1993.
  • Invited Speaker, "Enzymatic Disinsertion of the Vitreous Body," New Dimensions in Retina Symposium, Chicago, Illinois. , , 1993.
  • Speaker, "Anheuser-Busch Eye Institute Research Update," Anheuser-Busch Eye Institute Alumni and Residents Day, St. Louis University, St. Louis, Missouri. , , 1993.
  • Invited Speaker, "Compositional Changes in Human Interphotoreceptor Matrix Proteoglycans Associated with Macular Drusen," International Symposium on The Interphotoreceptor Matrix: Components and Functions, International Society for Eye Research, Stresa, Italy. , , 1992.
  • Invited Speaker, "Enzymatic Disinsertion of the Primate Vitreous Body", International Symposium on Vitreous Pathobiology, International Society for Eye Research, Stresa, Italy. , , 1992.
  • Speaker, "A Defect in Interphotoreceptor Matrix Composition Associated with Drusen," Anheuser-Busch Eye Institute Alumni and Residents Day, St. Louis University, St. Louis, Missouri. , , 1992.
  • Invited Faculty, "The Retinal Pigment Epithelium in Health and Macular Degeneration," Johns Hopkins Retinal Vascular Center Anniversary Meeting, Baltimore, Maryland. , , 1992.
  • Invited Speaker, “Molecular and Compositional Characterization of Interphotoreceptor Matrix Proteoglycans," International Symposium on Extracellular Matrix of Cornea and Other Ocular Tissues, International Society for Eye Research, Stresa, Italy. , , 1992.
  • Invited Speaker, "Do Interphotoreceptor Matrix Glycoconjugates Participate in Retinal Adhesion?", International Symposium on Epithelial Adhesion, International Society for Eye Research, Stresa, Italy. , , 1992.
  • Speaker, "Interphotoreceptor Binding Protein and Retinal Degeneration," and "Possible Etiology of Epiretinal Membranes Following Retinal Detachment”, Bethesda Eye Institute Annual Meeting, "Ophthalmic Lasers: Gateway to the Future," St. Louis, Missouri. , , 1990.
  • Speaker, "Participation of the Retinal Interphotoreceptor Matrix in Retinal Adhesion," Bethesda Eye Institute Annual Meeting, "Ophthalmic Lasers: Gateway to the Future," St. Louis, Missouri. , , 1990.
  • Invited Speaker, "Characterization of the Primate Retinal Interphotoreceptor Matrix," UCLA Symposium on Molecular and Cellular Biology Minisymposium Series, Steamboat Springs, Colorado. , , 1990.
  • Invited Speaker, "Manifestations of Photoreceptor Degeneration in the Interphotoreceptor Matrix," Satellite Meeting on Retinal Degenerations, Stockholm, Sweden. , , 1990.
  • Visiting Professor, "Cone Photoreceptor Matrix Sheaths: Structure, Composition and Function," Turku University, Turku, Finland. , , 1990.
  • Invited Speaker, "Structure and Composition of the Interphotoreceptor Matrix: The Cone Matrix Sheath," Western Regional Eye Conference, Timberline Lodge, Government Camp, Oregon. , , 1989.
  • Speaker, "Characterization of the Vitreoretinal Interface and Disinsertion of the Vitreous Body," Bethesda Eye Institute Alumni and Residents Day, St. Louis University, St. Louis, Missouri. , , 1989.
  • Invited Speaker, "Introduction to Historical Perspectives" and "Characterization of Cone Photoreceptor Matrix Sheath Structure, Composition, and Function," 8th International Congress of Eye Research, San Francisco, California. , , 1988.
  • Invited Speaker, "Structure, Composition and Potential Function of Primate Cone Matrix Sheaths," presented at the "Cell Biology of Retinal Detachment Symposium," 2nd Western Eye Research Conference, Lake Arrowhead, California. , , 1988.
  • Speaker, "Research at the Bethesda Eye Institute", Bethesda Homes and Hospital Executive Staff. , , 1987.
  • Invited Speaker, "Molecular and Structural Organization of the Extracellular Matrix Associated with Primate Cone Photoreceptors," presented at the "Cell Biology of Photoreceptors and Retinal Pigment Epithelium," 27th Annual Meeting of the American Society for the Cell Biology, St. Louis, Missouri. , , 1987.
  • Invited Speaker, “Characterization of Cone-Associated Interphotoreceptor Matrix Domains," Symposium on Morphological and Biological Characteristics of Cone Photoreceptors, 7th International Congress of Eye Research, Nagoya, Japan. , , 1986.
  • Invited Speaker, "Taurine-deficient Pigmented and Albino Rats: Early Retinal Abnormalities", "Stage-specific Appearance of Peanut Agglutinin-binding Cells in the Outer Nuclear Layer of rd Mice" and "Differential Rates of Photoreceptor Degeneration," Sendai Symposium on Retinal Degeneration, Sendai, Japan. , , 1986.
  • Invited Speaker, "Stage-specific Appearance of Peanut Agglutinin-binding Cells in the Outer Nuclear Layer of rd Mice", "Lectin Binding to Glycoconjugates of Vertebrate Photoreceptor Cells”, Symposium on Carbohydrates and Outer Segment-RPE Interactions, 7th International Congress of Eye Research, Nagoya, Japan. , , 1986.
  • Invited Speaker, "Stage-specific Appearance of Peanut Agglutinin-binding Cells in the Outer Nuclear Layer of rd Mice”, Taurine in the Photoreceptors: Effects of Taurine Deficiency," Symposium on Pineal-Retinal Relationships, NICHHD and the NEI, Sarasota, Florida. , , 1985.
  • Invited Speaker, "Biochemical Characterization and Morphological Localization of Lectin-Binding Glycoproteins in the Vertebrate Vitreous Body and Inner Limiting Membrane," Symposium on Vitreous Body, 6th International Congress of Eye Research, Alicante, Spain. , , 1984.
  • Invited Speaker, Foundation Fighting Blindness, "Age-related Macular Degeneration: Biological and Therapeutic Insights", sponsored by Foundation Fighting Blindness, Salt Lake City, Utah. , , 2010.
  • Invited Speaker, Foundation Fighting Blindness, Orange County Investor Research Symposium. “Age-related Macular Degeneration: Genetics & Complement-based Therapy”, sponsored by Foundation Fighting Blindness, Newport Beach, CA. , , 2009.
  • Invited Speaker, Iowa Donor Network, “Can Liver Transplant Provide Insights Related to Therapeutic Strategies for AMD?”, North Liberty, IA. , , 2008.
  • Invited Speaker, University of Iowa, Mini Medical School, “Medical Miracles: The Science of Saving Lives”, University of Iowa Carver College of Medicine. , , 2007.
  • Invited Speaker, University of Iowa, UIHC Morticians, “Progress in Elucidating AMD Through the Use of Human Donor Eyes”. , , 2004.
  • Invited Speaker, Iowa Lions Eye Bank, Technician’s Meeting, Updates. , , 2002.
  • Invited Speaker, Iowa Lions Eye Bank, Technician’s Meeting, “Update on UICMD Research Program”. , , 2001.
  • Invited Speaker, Iowa Donor Network, “The Role of Eye and Tissue Donation in Elucidating Pathways Associated with Age-Related Macular Degeneration”. , , 2001.
  • Invited Speaker, Fox Eye Laser and Cosmetic Institute, “A Unifying Hypothesis for Drusen Biogenesis and AMD”. , , 1999.
  • Invited Speaker, University of Iowa, Program for University of Iowa Retirees and Families, Social, Patient, and Family Services, “Age-Related Macular Degeneration”. , , 1999.
  • Invited Speaker, North American Conference of Lions Foundations, 9th annual conference, “Age-Related Macular Degeneration”. , , 1999.
  • Invited Speaker, Walden Place, “AMD, The University of Iowa Center for Macular Degeneration, and Eye Donation”, Retirement Center. , , 1998.
  • Invited Speaker, Oaknoll, “AMD, The University of Iowa Center for Macular Degeneration, and Eye Donation” Iowa Retirement Center. , , 1998.
  • Invited Speaker, Greenwood Manor Assisted Living, “AMD, The University of Iowa Center for Macular Degeneration, and Eye Donation”. , , 1998.
  • Invited Speaker, Veterans Administration Medical Center, “AMD, The University of Iowa Center for Macular Degeneration, and Eye Donation”, Iowa City. , , 1998.
  • Invited Speaker, Foundation Fighting Blindness, Iowa Affiliate, “AMD: Genetics and Inheritance Patterns”. , , 1998.
  • Invited Speaker, Foundation Fighting Blindness, “Genetics and The Inheritance Pattern”, Foundation Fighting Blindness Iowa Affiliate, Waterloo, Iowa. , , 1998.
  • Invited Speaker, Lions Club, “Review of Macular Degeneration Research and Treatment”, Iowa City. , , 1998.
  • Invited Speaker, St. Luke's Hospital, Cedar Rapids St. Luke’s Hospital, Low Vision Center, “AMD, The University of Iowa Center for Macular Degeneration, and Eye Donation”. , , 1998.
  • Presenter, Cedar Rapids Medical Education Foundation, Physician Grand Rounds, "Age Related Macular Degeneration and Other Eye Diseases. , , 1998.
  • Invited Speaker, Wickham Elementary, Various presentations and laboratory tours for Local Schools. , , 1997.
  • Invited Speaker, Kirkwood Jr. High, Various presentations and laboratory tours for Local Schools. , , 1997.
  • Invited Speaker, West High School, Various presentations and laboratory tours for Local Schools. , , 1997.
  • Presenter, Community Groups, Various lectures and presentations have been given to administrators, faculty and staff of The University of Iowa, local hospitals (including St. Luke's Hospital, Mercy Hospital, the Veteran's Administration Medical Center, and Mercy Medical Center), ISOPO, LifeNet, Iowa Donor Network (IDN), the Iowa City Medical Examiner, local retirement centers (Melrose Meadows, Atrium Village, Cottage Grove, Methwick Manor), senior centers (Iowa City, Amana), clubs and other organizations during the period between 1997 and present. These are numerous (>100) and are not listed individually. , , 1997.
  • Invited Speaker, Mid America Transplant Association, "Characterization of Interphotoreceptor Matrix in Eyes from Donors with Age-Related Macular Degeneration," St. Louis, Missouri. , , 1991.

Languages

  • English, Fluent.

Publications

  • Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH (date unknown). Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Vol. 121, 2415-22. Accepted, .
  • Keenan TD, Toso M, Pappas C, Nichols L, Bishop PN, Hageman GS (date unknown). Assessment of Proteins Associated With Complement Activation and Inflammation in Maculae of Human Donors Homozygous Risk at Chromosome 1 CFH-to-F13B. Vol. 56, 4870-9. Accepted, .
  • Finger RP, Wu Z, Luu CD, Kearney F, Ayton LN, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH (date unknown). Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization. Vol. 121, 1252-6. Accepted, .
  • Gorusupudi A, Liu A, Hageman GS, Bernstein PS (date unknown). Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers. Vol. 57, 499-508. Accepted, .
  • Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH (date unknown). Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degeneration. Vol. 56, 1546-52. Accepted, .